Biotech · Private company · Woodside, CA, US
Manzanita Pharmaceuticals, Inc.
Track this companyFree. Adds Manzanita Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancerFiscal year 2025 · $1.1MNIH RePORTER 5R44CA295214-02 · fetched Nov 12, 2026
- Toxicology (IND-enabling) studies for a novel nerve imaging agent for prostate cancerFiscal year 2024 · $905.5KNIH RePORTER 1R44CA295214-01 · fetched Nov 12, 2026